BIVI•benzinga•
BioVie Secures Full Funding For Upcoming Phase 2 Parkinson's Disease Trial Of Bezisterim, Set To Begin Early 2025 With Results Expected Late 2025; Recent $15M Raised From Secondary Offerings
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga